IGHE and anaphylaxis: According to own studies, the detection of so-called pre-existing IgE antibodies before the start of treatment with biologics is particularly important for the decision in favor of safe treatment, but tests to monitor IgE (ADA) development in the course of treatment are also important for managing the risk of developing anaphylaxis [1, 121, 122].